Pfizer says patient dies after receiving hemophilia drug in trial

Group 1 - A patient treated with Pfizer's hemophilia drug, Hympavzi, died after experiencing serious side effects [1] - The incident occurred as part of a long-term study [1] - Pfizer acknowledged the death and the associated serious side effects [1]